New Atopic Dermatitis Treatment Works Quickly, Has Fewer Side Effects Than Other Options
The U.S. Food and Drug Administration (FDA) has approved Zoryve (roflumilast) cream 0.15 percent for…
The U.S. Food and Drug Administration (FDA) has approved Zoryve (roflumilast) cream 0.15 percent for…
NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients…
— The Bipartisan NAPA Reauthorization Act, Alzheimer’s Accountability and Investment Act, BOLD Reauthorization Act and…
Multiple tampon brands on the market have been found to contain certain types of toxins,…
NIH modifies application and review process for fellowship grants to broaden scientific trainee pool The…
WASHINGTON, D.C., March 18, 2024 — The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM)…
Pop star Taylor Swift’s grip on our cultural imagination isn’t just getting some people to…
Doctors underutilize next-gen antibiotics to fight resistant infections in U.S. hospitals NIH scientists find clinicians…
— BOLD Reauthorization Act, NAPA Reauthorization Act, Alzheimer’s Accountability and Investment Act, and Lifespan Respite…
Although semaglutide (Ozempic, Wegovy) and other GLP-1 drugs have rapidly become infamous for a wide variety…